Ledger.Open graph →
SEC Form D · Amendment · filed January 8, 2025

Alcyone Therapeutics, Inc

Offering
$31.6M
Sold
$19.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
Lowell, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Pj Anand · Lowell, MAExec · DirectorDavid Donabedian · Lowell, MADirectorNorbert D. Riedel · Lowell, MADirectorRichard Upton · Lowell, MADirectorEdgar D. Jannotta · Lowell, MADirectorCameron Durrant · Lowell, MADirectorStephen D. Oesterle · Lowell, MADirectorRichard Upton · Lowell, MADirectorCameron Durrant · Lowell, MADirectorNorbert D. Riedel · Lowell, MADirectorEdgar D. Jannotta · Lowell, MADirectorDavid Donabedian · Lowell, MADirectorStephen D. Oesterle · Lowell, MADirectorPj Anand · Lowell, MAExec · DirectorHeath Wilson · Knoxville, TNDirectorJoseph Odom · Knoxville, TNDirectorLarry Page · Seattle, WADirectorSanjay Pal · Seattle, WAExec · DirectorTommi Unkuri · STOCKHOLM, V7DirectorChristian Melby · STOCKHOLM, V7DirectorReynir G. Indahl · STOCKHOLM, V7Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗